Abstract: Hypertrophic cardiomyopathy（HCM）is the most common heart disease in cats. HCM in cats is characterized by centripetal thickening of ventricular walls and papillary muscle hypertrophy. The incidence of HCM followed by thromboembolism（ATE）in cats is increasing year by year. The overall survival rate of HCM was as low as 35%. This article reviewed the diagnosis and treatment of HCM and ATE in cats focusing on the main therapeutic drugs and their efficacy. It is suggested to file the predisposed breeds as soon as possible，conduct regular physical examination and screening，provide timely treatment，perform breed selection，improve the techniques of surgical treatment and integrated traditional Chinese and western medicine，use drugs prudently for treating thrombosis，try to use new antithrombolytic drugs，and so on.

Key words: Arterial thrombosis； Cat； Hypertrophic cardiomyopathy； Diagnosis； Treatment

摘要： 肥厚性心肌病（Hypertrophic cardiomyopathy，HCM）是猫最常见的心脏病，特征是心 室壁向心性增厚并发乳头肌肥厚。猫HCM继发动脉血栓栓塞（Arterial thromboembolism，ATE） 检出率逐年升高，此病总体存活率低至35%，越来越受到重视。该文综述了猫HCM继发ATE 的诊断与治疗进展，并特别介绍了目前主要治疗药物及其疗效。提出针对好发品种尽早建 档，定期体检筛查，发病后及时送医；选育新品种；提高手术治疗和中西医结合治疗的技术；谨 慎使用治疗血栓药物，尝试使用新型抗栓溶栓药物等综合措施以期提高此病治愈率。

关键词: 动脉血栓； 猫； 肥厚性心肌病； 诊断； 治疗